Organized development from human embryonic stem cells after injection into immunodeficient mice. 2004

Karin Gertow, and Susanne Wolbank, and Björn Rozell, and Rachael Sugars, and Michael Andäng, and Clare L Parish, and Marta P Imreh, and Mikael Wendel, and Lars Ahrlund-Richter
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden. karin.gertow@crc.ki.se

Information concerning the development and differentiation of human embryonic stem (hES) cells in vivo is limited. The present study has focused on the in vivo outcome and differentiation of the hESC line HS181, after injection into SCID/beige mice. hES cell-derived teratomas were explored using histological evaluation and by the identification of markers for differentiated cells and tissues. The analyses identified predominant differentiation along a neuronal lineage, the formation of bone/cartilage and epithelia. Fluorescent in situ hybridization (FISH) analysis with a human-specific probe showed the teratomas to be mainly of human origin, with the most organized areas being exclusively human. Importantly, the study revealed interactions between mouse and human tissues, most notably in the formation of vessels. Both mouse and human cells contributed to specific microstructures in which mouse cells could be observed to take on the appropriate histiotypic appearance. Hence, HS181 cells were able to develop into defined mature tissues, supporting the relevant use of this hES cells model for studies of early human development, given the use of appropriate controls for host contribution. Although extensive mitotic activity implicated progenitor cell activity, no detectable multipotent or malignant areas were observed during the observation period. Persisting undifferentiated hESC were not detected.

UI MeSH Term Description Entries
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002356 Cartilage A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE. Cartilages
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013234 Stem Cells Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells. Colony-Forming Units,Mother Cells,Progenitor Cells,Colony-Forming Unit,Cell, Mother,Cell, Progenitor,Cell, Stem,Cells, Mother,Cells, Progenitor,Cells, Stem,Colony Forming Unit,Colony Forming Units,Mother Cell,Progenitor Cell,Stem Cell
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft
D016513 Mice, SCID Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice. SCID Mice,SCID-hu Mice,Severe Combined Immunodeficient Mice,Immunodeficient Mice, Severe Combined,Mouse, SCID,Mouse, SCID-hu,Mice, SCID-hu,Mouse, SCID hu,SCID Mouse,SCID hu Mice,SCID-hu Mouse
D017404 In Situ Hybridization, Fluorescence A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei. FISH Technique,Fluorescent in Situ Hybridization,Hybridization in Situ, Fluorescence,FISH Technic,Hybridization in Situ, Fluorescent,In Situ Hybridization, Fluorescent,FISH Technics,FISH Techniques,Technic, FISH,Technics, FISH,Technique, FISH,Techniques, FISH

Related Publications

Karin Gertow, and Susanne Wolbank, and Björn Rozell, and Rachael Sugars, and Michael Andäng, and Clare L Parish, and Marta P Imreh, and Mikael Wendel, and Lars Ahrlund-Richter
June 2018, Nature,
Karin Gertow, and Susanne Wolbank, and Björn Rozell, and Rachael Sugars, and Michael Andäng, and Clare L Parish, and Marta P Imreh, and Mikael Wendel, and Lars Ahrlund-Richter
January 2013, Cell transplantation,
Karin Gertow, and Susanne Wolbank, and Björn Rozell, and Rachael Sugars, and Michael Andäng, and Clare L Parish, and Marta P Imreh, and Mikael Wendel, and Lars Ahrlund-Richter
January 2016, The International journal of developmental biology,
Karin Gertow, and Susanne Wolbank, and Björn Rozell, and Rachael Sugars, and Michael Andäng, and Clare L Parish, and Marta P Imreh, and Mikael Wendel, and Lars Ahrlund-Richter
January 2007, Hematology. American Society of Hematology. Education Program,
Karin Gertow, and Susanne Wolbank, and Björn Rozell, and Rachael Sugars, and Michael Andäng, and Clare L Parish, and Marta P Imreh, and Mikael Wendel, and Lars Ahrlund-Richter
July 2008, The Journal of clinical investigation,
Karin Gertow, and Susanne Wolbank, and Björn Rozell, and Rachael Sugars, and Michael Andäng, and Clare L Parish, and Marta P Imreh, and Mikael Wendel, and Lars Ahrlund-Richter
December 1999, Proceedings of the National Academy of Sciences of the United States of America,
Karin Gertow, and Susanne Wolbank, and Björn Rozell, and Rachael Sugars, and Michael Andäng, and Clare L Parish, and Marta P Imreh, and Mikael Wendel, and Lars Ahrlund-Richter
April 2000, Theriogenology,
Karin Gertow, and Susanne Wolbank, and Björn Rozell, and Rachael Sugars, and Michael Andäng, and Clare L Parish, and Marta P Imreh, and Mikael Wendel, and Lars Ahrlund-Richter
December 2009, PloS one,
Karin Gertow, and Susanne Wolbank, and Björn Rozell, and Rachael Sugars, and Michael Andäng, and Clare L Parish, and Marta P Imreh, and Mikael Wendel, and Lars Ahrlund-Richter
December 2023, Journal of visualized experiments : JoVE,
Karin Gertow, and Susanne Wolbank, and Björn Rozell, and Rachael Sugars, and Michael Andäng, and Clare L Parish, and Marta P Imreh, and Mikael Wendel, and Lars Ahrlund-Richter
August 2006, Stem cells (Dayton, Ohio),
Copied contents to your clipboard!